Articles

Elsevier,

The Lancet Regional Health - Americas, Volume 37, September 2024

This viewpoint highlights the threat of gambling as an emerging public health issue in the American continent.
Elsevier,

Analytica Chimica Acta, Volume 1320, 1 September 2024

A non invasive way to test stress levels an monitor metal health in the work environment.
Elsevier,

Steroids, Volume 209, September 2024

Steroidal alkaloids from bioactive sources as a potential therapeutic approach to managing Alzheimer’s. It is a review, but I think it shines a really unique light in underexplored, and oft inexpensive, approaches.
Elsevier,

Journal of Neuroscience Methods, Volume 409, September 2024

Despite significant investment, effective treatments for Alzheimer's disease (AD) have been elusive, necessitating improved quality and reproducibility of foundational laboratory evidence; to address this, AD-SOLES, an integrated workflow of automated tools and a publicly accessible interactive dashboard, has been developed to collect, curate, and visualize in vivo experimental evidence, enhancing evidence synthesis, tracking reporting quality, and aiding researchers in locating relevant data.
Elsevier,

Journal for Nurse Practitioners, Volume 20, September 2024

Nurse practitioners and other health care providers can play a crucial role in implementing chronic disease management strategies and educating patients who are at risk for AD among African Americans and Hispanics.
Elsevier,

Pharmacological Research - Modern Chinese Medicine, Volume 12, September 2024

The study investigates the neuroprotective effects of hordenine against AlCl3-induced Alzheimer’s disease in rats. Results show that hordenine improves memory and cognitive functions, suggesting its potential to reverse oxidative stress and neuroinflammation associated with Alzheimer’s
Elsevier,

Brain Research, Volume 1838, 1 September 2024

The study demonstrates that the peptide PHDP5, which inhibits dynamin-MT interaction, can rescue impaired endocytosis and synaptic transmission caused by tau in presynaptic terminals. When administered intranasally to Alzheimer's disease (AD) model mice, PHDP5 significantly improved learning and memory, suggesting its potential as a candidate for human AD therapy.
Elsevier,

Australian and New Zealand Journal of Public Health, Volume 48, August 2024

This paper seeks to describe and categorise some of the most common behaviours and practices of public health professionals and institutions that introduce or sustain systematic ethnic bias into public health work and thus potentially perpetuate or exacerbate Indigenous inequities in health.
Elsevier,

The American Journal of Medicine, Available online 27 August 2024

The present mini-commentary on Alzheimer's disease describes recently revealed pathogenic elements, evolving capabilities for identifying unusually high individual susceptibility and developing tests that predict onset preclinically to allow preventative approaches. Several potential therapies that target cellular signaling and other pathways that are abnormal in Alzheimer's disease are in early clinical trials and will be reviewed briefly.

Elsevier,

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Volume 134, 30 August 2024

This study evaluated the behavioral, physiological, and molecular effects of social isolation (SI) in adult zebrafish, and whether the animals recover such changes after their reintroduction to the social environment. The results show that SI altered social behaviors, neural activity, and serotonergic and dopaminergic signaling in zebrafish, but these changes were reversed after the animals were reintroduced to a social context for 6 days.

Pages